Today: 5 March 2026
Browse Category

Earnings Reports 5 February 2026

CapitaLand Investment share price today: 9CI slips after China unit wind-up filing, earnings next week in focus

CapitaLand Investment share price today: 9CI slips after China unit wind-up filing, earnings next week in focus

CapitaLand Investment shares fell 1% to S$3.08 in mid-afternoon trading after announcing the voluntary liquidation of a dormant China subsidiary, with no significant financial impact expected. The company is set to release full-year results on Feb. 11. CapitaLand China Trust’s manager reported a drop in FY2025 distribution per unit, citing a weaker renminbi. Sustainability head Vinamra Srivastava will step down, with Andrew Jasudasen named as successor.
DBS share price edges up near S$60 as traders brace for earnings in risk-off Asia

DBS share price edges up near S$60 as traders brace for earnings in risk-off Asia

DBS shares rose 0.4% to S$59.57 in Thursday afternoon trading, with about 2.5 million shares exchanged. The stock hovered just below its 12-month high as investors positioned ahead of next week’s earnings and dividend announcement. Singapore’s STI closed at a record high Wednesday, lifted by gains in local banks. Broader Asian markets slipped after a tech-led selloff on Wall Street.
Evolution Mining share price slides after gold rout; what to watch before next week’s results

Evolution Mining share price slides after gold rout; what to watch before next week’s results

Evolution Mining shares fell 3.2% to around A$14.54 Thursday as gold prices slid 2.5% to $4,838.81 an ounce and the S&P/ASX 200 lost 0.4%. Gold stocks dropped 4.6% amid a stronger U.S. dollar and risk-off sentiment. Evolution will report half-year results on Feb. 11, with investors watching for cost and production updates.
Carvana stock falls 4%: what CVNA traders are watching before Feb. 18 earnings

Carvana stock falls 4%: what CVNA traders are watching before Feb. 18 earnings

Carvana shares fell 4.3% to $393.04 Wednesday, swinging between $366.62 and $410.52 during the session. COO Benjamin Huston sold shares on Feb. 3 under a preset trading plan, according to an SEC filing. Rosen Law Firm said it is investigating possible securities claims against Carvana. The company will report fourth-quarter and full-year earnings after markets close Feb. 18.
Constellation Energy stock sinks nearly 7% as PJM price-cap push keeps traders cautious ahead of earnings

Constellation Energy stock sinks nearly 7% as PJM price-cap push keeps traders cautious ahead of earnings

Constellation Energy shares fell 6.7% to $250.46 Wednesday on heavy volume after Washington pressed PJM to cap power prices and speed up grid connections for data centers. The drop came despite Constellation’s recent $7 billion Calpine acquisition, which made it the largest U.S. electricity producer. Other wholesale power stocks also declined, while NextEra Energy rose 1.3%.
CrowdStrike stock slides again: AI jitters, insider filings and March earnings loom

CrowdStrike stock slides again: AI jitters, insider filings and March earnings loom

CrowdStrike shares fell 1.5% to $415.36 Wednesday, extending a six-day losing streak and leaving the stock 27% below its November peak. Trading volume hit 4.7 million shares. The drop followed insider sale disclosures and a broader $830 billion selloff in software stocks amid AI disruption fears. Investors now await CrowdStrike’s March 3 earnings report.
Analog Devices stock pops as chip dealmaking back in focus ahead of ADI earnings

Analog Devices stock pops as chip dealmaking back in focus ahead of ADI earnings

Analog Devices shares rose 3% to $320.44 Wednesday, bucking declines in major chip stocks. The move followed Texas Instruments’ $7.5 billion deal to buy Silicon Labs, drawing attention to the analog chip sector. Trading volume in ADI topped its recent average. Investors are focused on ADI’s Feb. 18 earnings for signals on demand and margins.
Amgen stock jumps 8% after earnings beat — what to know before Thursday’s open

Amgen stock jumps 8% after earnings beat — what to know before Thursday’s open

Amgen shares surged 8.2% to $366.20 Wednesday after quarterly earnings beat forecasts and the company issued a 2026 outlook above consensus. Investors focused on progress in Amgen’s MariTide obesity program, which could allow less frequent dosing. The company reported Q4 revenue of $9.9 billion and adjusted EPS of $5.29. Amgen plans $2.6 billion in 2026 capital spending and capped share buybacks at $3 billion.
Coca-Cola stock steadies after CEO Quincey’s sale filing as Wall Street braces for Feb. 10 results

Coca-Cola stock steadies after CEO Quincey’s sale filing as Wall Street braces for Feb. 10 results

Coca-Cola closed up 0.6% at $77.35 on Wednesday, steadying after hours as an SEC filing showed CEO James Quincey plans to sell about 337,824 shares worth $25.4 million. Jefferies raised its price target to $88 ahead of next week’s earnings. UBS cited expectations for another “on-algorithm” year. The planned sale represents less than 0.01% of Coke’s outstanding shares.
PayPal stock price slips after-hours as CEO shake-up and weak 2026 outlook keep PYPL under pressure

PayPal stock price slips after-hours as CEO shake-up and weak 2026 outlook keep PYPL under pressure

PayPal shares fell 1.6% to $41.03 in after-hours trading Wednesday after the company named HP’s Enrique Lores as CEO, replacing Alex Chriss. The stock drop followed weak 2026 profit guidance and a slowdown in branded checkout growth. PayPal reported Q4 revenue of $8.68 billion and adjusted EPS of $1.23, but scrapped its 2027 targets. CFO Jamie Miller will serve as interim CEO until March 1.
5 February 2026
Bloom Energy stock slides in after-hours as traders brace for Thursday earnings

Bloom Energy stock slides in after-hours as traders brace for Thursday earnings

Bloom Energy shares dropped 12.8% to $147.35 in after-hours trading Wednesday after a volatile session. Wall Street expects fourth-quarter profits to fall from last year despite higher revenue, with analysts forecasting $0.25 per share on $649.12 million in sales. Investors are focused on guidance and orders tied to data-center power demand. Bloom reports earnings Thursday after the close.
Merck stock rises after-hours as cautious 2026 forecast meets new cholesterol pill headlines

Merck stock rises after-hours as cautious 2026 forecast meets new cholesterol pill headlines

Merck shares rose 2.2% to $118.33 in after-hours trading Wednesday after new data showed its experimental cholesterol drug enlicitide cut LDL by up to 60% in a major trial. The company’s 2026 revenue forecast of $65.5–$67.0 billion missed Wall Street estimates, citing pressure from off-patent drugs and U.S. pricing. Keytruda sales reached $8.37 billion last quarter, while Gardasil revenue fell 34%.
1 31 32 33 34 35 226
Go toTop